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Miller-Fisher syndrome (MFS) is a rare condition characterized by the classical triad of ophthalmoplegia, ataxia, and areﬂexia
(Fisher, 1956). It is considered a variant of Guillain-Barr´ e syndrome (GBS) with which it may overlap, or it can occur in more
limited forms. We report a case of a thirty-ﬁve-year-old male who presented with a six-day history of diplopia, following a recent
chest infection. On examination, he was found to have bilateral sixth nerve palsy, bilateral fourth nerve palsy, bilateral areﬂexical
mydriasis, ataxia and total absence of reﬂexes. After excluding other conditions, a diagnosis of Miller-Fisher syndrome was made.
The patient was administered intravenous immunoglobulin and made an uneventful recovery.
1.CaseReport
A thirty-ﬁve-year-old male patient presented to our depart-
ment complaining of diplopia of 6 days duration. He was
generallyﬁtandwellwithnosigniﬁcantpastmedicalhistory.
Ten days previously, he had suﬀered a chest infection for
which he had a course of antibiotics and had made a good
recovery.
On examination, his visual acuity was 6/5 unaided
bilaterally.
ColourvisiontestedwithIshiharaplateswasnormal,and
visual ﬁeld testing by confrontation was also normal.
Both pupils were dilated and were not reacting to light
and accommodation. (Figures 1, 2,a n d3).
Ocular motility testing revealed signs suggesting bilateral
fourth nerve palsy and bilateral sixth nerve palsy.
The remainder of the cranial nerves were intact.
Anterior segment examination and fundoscopy were
normal on both sides.
All his reﬂexes were absent and he had truncal unsteadi-
ness when carrying out heel-to-toe walking. A formal
orthoptic assessment was carried out which veriﬁed the
presence of bilateral fourth and sixth nerve palsy (Figures 4,
5, 6, 7, 8, 9,a n d10).
Pharmacological testing with 0,125% Pilocarpine caused
miosis on both sides.
Subsequently, the patient had a brain MRI scan that did
not reveal any abnormalities.
On the basis of the clinical ﬁndings a diagnosis of Miller
Fisher syndrome was made. Serum samples were tested for
anti-GQ1b ganglioside antibodies and an elevated IgG titer
was reported.
The patient was referred to a neurologist. He did not
undergo CSF examination. He was administered intravenous
immunoglobulin and made an uneventful recovery within
ten weeks.2 Journal of Ophthalmology
Figure 1: Bilaterally dilated pupils with absent response to light
w h e nl i g h ti ss h o w nt ot h el e f te y e .
Figure 2: Bilaterally dilated pupils with absent response to light
when light is shown to the right eye.
Figure 3: Absent pupil response to accommodation of both eyes
a n dn o r m a lc o n v e r g e n c e .
Figure 4: Right esotropia.
Figure 5: Left esotropia.
Figure 6: Underaction of left eye on laevoversion.
Figure 7: Full abduction of left eye on ductions.
Figure 8: Underaction of right eye on dextroversion.
Figure 9: Full abduction of right eye on ductions.Journal of Ophthalmology 3
Figure 10: Hess chart showing bilateral fourth and sixth nerve palsy.
2. Discussion
Miller-Fisher syndrome is considered a variant of Guillain-
Barr´ e syndrome.
It was ﬁrst described in 1956 as a triad of ophthalmople-
gia, ataxia, and areﬂexia [1].
The pathogenesis is considered immunological [2],
molecular mimicry being the most likely mechanism [3].
Anti-GQ1bgangliosideantibodieshavebeenshowntobe
a serum marker for MFS [4]. They can be found in 85% of
casesandhavebeenproposedasoneofthediagnosticcriteria
for MFS. An MRI of the brain is not necessary to make
the diagnosis which can be made solely on clinical grounds
having excluded other pathology [5]. Usually, abnormal high
intensity lesions of the brainstem, thalamus, cerebellum, and
cerebrum are seen on MRI in patients with Bickerstaﬀ’s
brainstem encephalitis with ophthalmoplegia, ataxia and
hypereﬂexia [6].
The diﬀerential diagnosis also includes botulism [7],
cerebrovascular accident, myasthenia gravis, and Wernicke’s
encephalopathy with the latter being the one closer mim-
icking MFS, usually presenting with mental changes, ataxia,
and extraocular muscle paralysis with nystagmus in a
person with nutritional deﬁciency precipitated by infection,
gastrointestinal disorder or trauma [8].
Avarietyofinfectionscanprecedetheonsetofsymptoms
[9].
T h ef u l lt r i a do fM F Si sn o ta l w a y sp r e s e n t[ 5]a n d
there might be an overlap with GBS [10]. Mydriasis which
exhibits denervation hypersensitivity with or without light-
near dissociation is also not always present [11].
The natural recovery of the condition is very good in the
majority of cases with or without treatment [12].
There are no randomised controlled trials of im-
munomodulatory therapy in MFS on which to base practice
yet [13]. The role of plasmapheresis in the treatment of MFS
is controversial. Some studies have shown beneﬁt [14] while
others failed to do so [15]. Intravenous immunoglobulin
has been shown to slightly hasten the periods between
ophthalmoplegia and ataxia onset and the start of the
alleviation of these symptoms [16].
Ophthalmologists should maintain a high level of suspi-
cionofMFSastheymaybetheﬁrstdoctorstoencounterthis
condition.
Careful history taking and the bilaterality of the con-
dition are keys to the diagnosis even though unilateral
cases have been reported. After other pathology has been
excluded, a prompt referral to a neurologist is mandatory
as the condition may progress to GBS [12] with devastating
consequences.
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